Navigation Links
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
Date:6/14/2013

l therapies and their potential role in treating various types of hematologic cancers and solid tumors. The alliance intends to transform cancer care by harnessing the expertise in fundamental science and medicine at both UCSF and Onyx to address the full continuum of that care, from prediction and diagnosis to new therapies and post-treatment monitoring, to identify opportunities to improve the patient experience and outcomes. The term of the agreement extends for three years. The Full Research Report on Onyx Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/fcf8_ONXX]

--

Questcor Pharmaceuticals, Inc. Research Report

On June 10, 2013, Questcor Pharmaceuticals, Inc. (Questcor) announced the addition of Angus C. Russell, recently-retired CEO of Shire plc, to Questcor's Board of Directors. "Angus is a respected biopharmaceutical industry leader with a proven track in specialty pharmaceuticals," said Virgil D. Thompson, Chairman of Questcor's Board of Directors. "We look forward to benefitting from Angus' 32 years of experience in the specialty pharmaceutical industry as we continue to focus on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders." "The growth of scientific knowledge regarding the importance of melanocortin receptors in immunomodulation provides Questcor with a large potential growth opportunity over the next few years," Angus added. Further, on May 29, 2013, the Company's Board of Directors declared a quarterly cash dividend of $0.25 per share to shareholders of record at the close of business on July 22, 2013, payable on or about July 30, 2013. The Full Research Report on Questcor Pharmaceuticals, Inc. - including full det
'/>"/>

SOURCE Wall Street Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
4. Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
5. Net Medical Xpress Q3 Revenue Up 34% With Ongoing Launch of New Telemedicine Services
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Microfabrica To Introduce Educational Series For Design Engineers Challenged With Ongoing Drive To Miniaturization
8. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
9. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
10. Pfizer Identifies Synexus South African Clinical Research Sites as INSPIRE Sites - First in Africa
11. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...   BioClinica®, Inc ., a specialty clinical ... it has acquired a leading global patient recruitment ...  The acquisition includes affiliates MediciGlobal , Ltd. ... a lost-to-follow-up patient locate service ( L2FU®) ... BioClinica will offer pharmaceutical companies comprehensive ...
(Date:7/6/2015)... Hologic, Inc. (NASDAQ: HOLX ) announced ... results for the third quarter of fiscal 2015 on ... conjunction with the release, management will host a conference ... Interested participants may listen to the call by ... ) or 719-325-4804 (for international callers) and referencing access ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, 2015 ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... E warrants to purchase 21,917,808 shares of its ... 2,191,781 shares of its common stock.  Certain funds ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
(Date:7/6/2015)... ... July 06, 2015 , ... ... radiology services and ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, ... their Top 10 Tips for ICD-10. The ten tips are timely and relevant ...
(Date:7/6/2015)... ... 2015 , ... Cancer Hope Network (CHN) has relaunched their ... to chat with the CHN patient services team and connect with a Support ... often the most traumatic experience of a person’s life,” said CHN Executive Director, ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a ... once again teamed up with Family Emergency Shelter Coalition (FESCO) and announced a ... FESCO was created especially to provide emergency services and support for homeless families, ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community program ... Livonia Save Our Youth and announced a new charity campaign to raise funds in ... alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially to ...
(Date:7/6/2015)... ... ... Dr. Lawrence Green is now offering the newly FDA-approved Kybella injectable to ... method to dissolve fat cells and is the first of its kind to be ... commonly known as a double chin. Dr. Green participated in clinical trials for Kybella ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... July 13, 2010 The decision regarding treatment following ... (DCIS) has long been an area of discussion and ... rates for DCIS remain low, the risk of local ... surgery include radiation therapy and hormone treatment. While ...
... Science Associates, the company that manages the U.S. ... Engineering Technologies, Inc. (BioSET) of Rockville, Maryland, have ... second-generation technology for designing synthetic peptides that are ... are designed to communicate growth signals to cells ...
... HealthDay Reporter , TUESDAY, July 13 (HealthDay News) -- ... decade ago that the blockbuster diabetes drug caused an increased ... to a report published Tuesday in The New York ... its competitor, Actos, the drug company, then known as SmithKline ...
... ARBOR, Mich.---Dostoyevsky and Tolstoy portrayed Russians as a brooding, ... to focus on dark feelings and memories more than ... finds that even though Russians tend to brood, they ... as a result. "Among Westerners, focusing on one,s ...
... health threats ranging from swine flu to bioterrorism to ... vast potential to protect the public. In a paper ... in Emerging Health Threats Journal , public health ... surveillance, detailing innovations on the horizon that may facilitate ...
... Children and young adults with Tourette syndrome can gain control ... suggests. But a specialist in the condition said the ... works. In the study, reported in the July/August ... , researchers used a video to teach 33 people aged ...
Cached Medicine News:Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 2Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 3Health News:Brookhaven Lab and BioSET Inc. patent improved growth factor technology 2Health News:Avandia Heart Risks Buried by Drug Company: Report 2Health News:Avandia Heart Risks Buried by Drug Company: Report 3Health News:Brooding Russians: Less distressed than Americans 2Health News:Researchers envision better disease surveillance to improve public health 2Health News:Can Self-Hypnosis Help Tourette Patients Control Tics? 2
Intermittent catheter...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions....
... Flexible Band is a flexible partial ... alternative for surgeons who desire posterior ... Tailor® Annuloplasty Ring, which is designed ... rings, but like the option of ...
Medicine Products: